Filing Details
- Accession Number:
- 0001209191-21-012543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-19 19:07:22
- Reporting Period:
- 2021-02-17
- Accepted Time:
- 2021-02-19 19:07:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1016169 | Antares Pharma Inc. | ATRS | Surgical & Medical Instruments & Apparatus (3841) | 411350192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235635 | J Peter Graham | C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628 | Evp General Counsel, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-17 | 80,365 | $0.00 | 582,490 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-02-17 | 42,073 | $4.73 | 540,417 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-18 | 45,000 | $1.12 | 585,417 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-18 | 40,000 | $4.91 | 545,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-18 | 5,000 | $5.05 | 540,417 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-02-18 | 45,000 | $0.00 | 45,000 | $1.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-06-01 | No | 4 | M | Direct |
Footnotes
- On June 8, 2018, Mr. Graham was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three-year performance period ended December 31, 2020. The number of shares acquired represent the total number of shares earned upon achievement of certain performance goals, which was certified and vested on February 17, 2021. The shares of common stock disposed represents the number of shares withheld by the company to settle tax liability in connection with the vesting of the performance stock unit award and were not actually sold.
- This stock option exercise and sale of common stock was effected pursuant to a Rule 10b5-1 trading plan.
- The options vested and became exercisable in equal quarterly installments over the three-year period following the grant date of June 2, 2016.
Billionaire Hedge Funds
